MiscellaneousComparison of Aspirin Resistance in Type 1 Versus Type 2 Diabetes Mellitus
References (20)
- et al.
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
Am J Cardiol
(2001) - et al.
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
J Am Coll Cardiol
(2003) - et al.
Aspirin resistanceposition paper of the Working Group on Aspirin Resistance
J Thromb Haemost
(2005) - et al.
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease
Thromb Res
(2002) - et al.
Low-dose aspirin increases aspirin resistance in patients with coronary artery disease
Am J Med
(2005) - et al.
Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA
Am J Cardiol
(2003) Collaborative overview of randomised trials of antiplatelet therapy—Iprevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
BMJ
(1994)- et al.
Primary prevention of cardiovascular events with low-dose aspirin and Vitamin E in type 2 diabetic patientsresults of the Primary Prevention Project (PPP) trial
Diabetes Care
(2003) - et al.
Prevalence, profile and predictors of aspirin resistance measured by the Ultegra Rapid Platelet Function Assay-ASA in patients with coronary artery disease
J Am Coll Cardiol
(2005) - et al.
The platelet in diabetesfocus on prevention of ischemic events
Diabetes Care
(2003)
There are more references available in the full text version of this article.
Cited by (56)
Interventions for coronary artery disease (Surgery vs Angioplasty) in diabetic patients
2014, Endocrinology and Metabolism Clinics of North AmericaCitation Excerpt :The issue of acetylsalicylic acid (ASA) resistance is significant in revascularized patients with DM.80 More than 20% of patients with DM seem to be ASA resistant.81 Colchicine may reduce ISR and TVR in BMS used for patient with DM who have contraindications to dual antiplatelet therapy.82
Use of antiaggregants in diabetes
2010, Avances en DiabetologiaAspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus
2010, Journal of Clinical Endocrinology and MetabolismThrombopoietin contributes to enhanced platelet activation in patients with type 1 diabetes mellitus
2021, International Journal of Molecular SciencesSex-and gender-based pharmacological response to drugs<sup>s</sup>
2021, Pharmacological ReviewsThe main determinants of diabetes mellitus vascular complications: Endothelial dysfunction and platelet hyperaggregation
2018, International Journal of Molecular Sciences
Dr. Goldfine was supported by Grant NIH K23-DK02795 from the National Institutes of Health, Bethesda, Maryland. Dr. Silver was supported by the William Randolph Hearst Foundation, New York, New York.
Copyright © 2006 Elsevier Inc. All rights reserved.